213 related articles for article (PubMed ID: 24815943)
1. Novel hydrophobin-coated docetaxel nanoparticles for intravenous delivery: in vitro characteristics and in vivo performance.
Fang G; Tang B; Liu Z; Gou J; Zhang Y; Xu H; Tang X
Eur J Pharm Sci; 2014 Aug; 60():1-9. PubMed ID: 24815943
[TBL] [Abstract][Full Text] [Related]
2. Denatured protein-coated docetaxel nanoparticles: Alterable drug state and cytosolic delivery.
Zhang L; Xiao Q; Wang Y; Zhang C; He W; Yin L
Int J Pharm; 2017 May; 523(1):1-14. PubMed ID: 28323094
[TBL] [Abstract][Full Text] [Related]
3. Docetaxel-loaded-lipid-based-nanosuspensions (DTX-LNS): preparation, pharmacokinetics, tissue distribution and antitumor activity.
Wang L; Liu Z; Liu D; Liu C; Juan Z; Zhang N
Int J Pharm; 2011 Jul; 413(1-2):194-201. PubMed ID: 21540085
[TBL] [Abstract][Full Text] [Related]
4. PEG-PCL based micelle hydrogels as oral docetaxel delivery systems for breast cancer therapy.
Wang Y; Chen L; Tan L; Zhao Q; Luo F; Wei Y; Qian Z
Biomaterials; 2014 Aug; 35(25):6972-85. PubMed ID: 24836952
[TBL] [Abstract][Full Text] [Related]
5. N-octyl-O-sulfate chitosan-modified liposomes for delivery of docetaxel: preparation, characterization, and pharmacokinetics.
Qu G; Wu X; Yin L; Zhang C
Biomed Pharmacother; 2012 Feb; 66(1):46-51. PubMed ID: 22264883
[TBL] [Abstract][Full Text] [Related]
6. Self-reporter shikonin-Act-loaded solid lipid nanoparticle: formulation, physicochemical characterization and geno/cytotoxicity evaluation.
Eskandani M; Nazemiyeh H
Eur J Pharm Sci; 2014 Aug; 59():49-57. PubMed ID: 24768857
[TBL] [Abstract][Full Text] [Related]
7. Antitumor activity of docetaxel-loaded polymeric nanoparticles fabricated by Shirasu porous glass membrane-emulsification technique.
Yu Y; Tan S; Zhao S; Zhuang X; Song Q; Wang Y; Zhou Q; Zhang Z
Int J Nanomedicine; 2013; 8():2641-52. PubMed ID: 23935362
[TBL] [Abstract][Full Text] [Related]
8. Biodegradable core-shell nanoassemblies for the delivery of docetaxel and Zn(II)-phthalocyanine inspired by combination therapy for cancer.
Conte C; Ungaro F; Maglio G; Tirino P; Siracusano G; Sciortino MT; Leone N; Palma G; Barbieri A; Arra C; Mazzaglia A; Quaglia F
J Control Release; 2013 Apr; 167(1):40-52. PubMed ID: 23298613
[TBL] [Abstract][Full Text] [Related]
9. Crafting Docetaxel-Loaded Albumin Nanoparticles Through a Novel Thermal-Driven Self-Assembly/Microfluidic Combination Technology: Formulation, Process Optimization, Stability, and Bioavailability.
Du J; Shi LL; Jiang WW; Liu XA; Wu XH; Huang XX; Huo MW; Shi LZ; Dong J; Jiang X; Huang R; Cao QR; Zhang W
Int J Nanomedicine; 2024; 19():5071-5094. PubMed ID: 38846644
[TBL] [Abstract][Full Text] [Related]
10. Cellular cytotoxicity and in-vivo biodistribution of docetaxel poly(lactide-co-glycolide) nanoparticles.
Esmaeili F; Dinarvand R; Ghahremani MH; Ostad SN; Esmaily H; Atyabi F
Anticancer Drugs; 2010 Jan; 21(1):43-52. PubMed ID: 19809300
[TBL] [Abstract][Full Text] [Related]
11. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
Feng SS; Mei L; Anitha P; Gan CW; Zhou W
Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
[TBL] [Abstract][Full Text] [Related]
12. Sulfobutylether-β-cyclodextrin/chitosan nanoparticles enhance the oral permeability and bioavailability of docetaxel.
Wu J; Shen Q; Fang L
Drug Dev Ind Pharm; 2013 Jul; 39(7):1010-9. PubMed ID: 22681515
[TBL] [Abstract][Full Text] [Related]
13. Tumour microenvironment-responsive lipoic acid nanoparticles for targeted delivery of docetaxel to lung cancer.
Gu F; Hu C; Tai Z; Yao C; Tian J; Zhang L; Xia Q; Gong C; Gao Y; Gao S
Sci Rep; 2016 Nov; 6():36281. PubMed ID: 27805051
[TBL] [Abstract][Full Text] [Related]
14. Successful delivery of docetaxel to rat brain using experimentally developed nanoliposome: a treatment strategy for brain tumor.
Shaw TK; Mandal D; Dey G; Pal MM; Paul P; Chakraborty S; Ali KA; Mukherjee B; Bandyopadhyay AK; Mandal M
Drug Deliv; 2017 Nov; 24(1):346-357. PubMed ID: 28165821
[TBL] [Abstract][Full Text] [Related]
15. Folic acid functionalized long-circulating co-encapsulated docetaxel and curcumin solid lipid nanoparticles: In vitro evaluation, pharmacokinetic and biodistribution in rats.
Pawar H; Surapaneni SK; Tikoo K; Singh C; Burman R; Gill MS; Suresh S
Drug Deliv; 2016 May; 23(4):1453-68. PubMed ID: 26878325
[TBL] [Abstract][Full Text] [Related]
16. Docetaxel-Loaded Lecithoid Nanoparticles with Enhanced Lung Targeting Efficiency and Reduced Systemic Toxicity: Developed by Solid Dispersion and Effervescent Techniques.
Zhang L; Liu ZH; Cheng XG; Xia Z; Liu Y; Yu Y
Chem Pharm Bull (Tokyo); 2017 Oct; 65(10):959-966. PubMed ID: 28781335
[TBL] [Abstract][Full Text] [Related]
17. Antitumor activity of PEGylated biodegradable nanoparticles for sustained release of docetaxel in triple-negative breast cancer.
Palma G; Conte C; Barbieri A; Bimonte S; Luciano A; Rea D; Ungaro F; Tirino P; Quaglia F; Arra C
Int J Pharm; 2014 Oct; 473(1-2):55-63. PubMed ID: 24992317
[TBL] [Abstract][Full Text] [Related]
18. Enhanced Antitumor Efficacy of Curcumin-Loaded PLGA Nanoparticles Coated with Unique Fungal Hydrophobin.
Sun L; Xu H; Xu JH; Wang SN; Wang JW; Zhang HF; Jia WR; Li LS
AAPS PharmSciTech; 2020 Jun; 21(5):171. PubMed ID: 32529560
[TBL] [Abstract][Full Text] [Related]
19. Formulation of a Sustained Release Docetaxel Loaded Cockle Shell-Derived Calcium Carbonate Nanoparticles against Breast Cancer.
Hammadi NI; Abba Y; Hezmee MNM; Razak ISA; Jaji AZ; Isa T; Mahmood SK; Zakaria MZAB
Pharm Res; 2017 Jun; 34(6):1193-1203. PubMed ID: 28382563
[TBL] [Abstract][Full Text] [Related]
20. Sustained release docetaxel-incorporated lipid nanoparticles with improved pharmacokinetics for oral and parenteral administration.
Qureshi OS; Kim HS; Zeb A; Choi JS; Kim HS; Kwon JE; Kim MS; Kang JH; Ryou C; Park JS; Kim JK
J Microencapsul; 2017 May; 34(3):250-261. PubMed ID: 28557649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
